DE69709628D1 - Verwendung von n-aryl-2-hydroxyalkylamiden zur induzierung und/oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls - Google Patents

Verwendung von n-aryl-2-hydroxyalkylamiden zur induzierung und/oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls

Info

Publication number
DE69709628D1
DE69709628D1 DE69709628T DE69709628T DE69709628D1 DE 69709628 D1 DE69709628 D1 DE 69709628D1 DE 69709628 T DE69709628 T DE 69709628T DE 69709628 T DE69709628 T DE 69709628T DE 69709628 D1 DE69709628 D1 DE 69709628D1
Authority
DE
Germany
Prior art keywords
hydroxyalkylamides
inducing
aryl
slowing down
hair growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69709628T
Other languages
English (en)
Other versions
DE69709628T2 (de
Inventor
Lionel Breton
Jean-Baptiste Galey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9602828A external-priority patent/FR2745717B1/fr
Priority claimed from FR9604362A external-priority patent/FR2747039B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE69709628D1 publication Critical patent/DE69709628D1/de
Publication of DE69709628T2 publication Critical patent/DE69709628T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69709628T 1996-03-06 1997-03-05 Verwendung von N-Aryl-2-hydroxy-alkylamiden zur Insuzierung und / oder Stimulation des Haarwachstums und/ oder zur Verlangsamung des Haarausfalls Expired - Fee Related DE69709628T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9602828A FR2745717B1 (fr) 1996-03-06 1996-03-06 Utilisation de n-aryl-2-hydroxyalkylamides pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR9604362A FR2747039B1 (fr) 1996-04-05 1996-04-05 Utilisation du n-(3,4-dicyano-phenyl)- 3,3,3-trifluoro- 2-hydroxy-2-methylpropionamide pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
PCT/FR1997/000389 WO1997032562A1 (fr) 1996-03-06 1997-03-05 Utilisation de n-aryl-2-hydroxyalkylamides pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute

Publications (2)

Publication Number Publication Date
DE69709628D1 true DE69709628D1 (de) 2002-02-21
DE69709628T2 DE69709628T2 (de) 2002-11-14

Family

ID=26232569

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69709628T Expired - Fee Related DE69709628T2 (de) 1996-03-06 1997-03-05 Verwendung von N-Aryl-2-hydroxy-alkylamiden zur Insuzierung und / oder Stimulation des Haarwachstums und/ oder zur Verlangsamung des Haarausfalls

Country Status (9)

Country Link
US (1) US6291532B1 (de)
EP (1) EP0886515B1 (de)
JP (1) JP2000508296A (de)
AT (1) ATE211903T1 (de)
AU (1) AU2030397A (de)
CA (1) CA2248198C (de)
DE (1) DE69709628T2 (de)
ES (1) ES2171894T3 (de)
WO (1) WO1997032562A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2770842B1 (fr) * 1997-11-13 1999-12-17 Oreal Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
DE19845202A1 (de) 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
FR2791671B1 (fr) 1999-04-01 2001-05-11 Oreal Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation
US20050112050A1 (en) * 2003-11-21 2005-05-26 Pradhan Bhabendra K. Process to reduce the pre-reduction step for catalysts for nanocarbon synthesis
FR2918885B1 (fr) 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
FR2939435B1 (fr) * 2008-12-09 2010-12-17 Oreal Esters de l'acide 5-(phenylsulfonyl)-2-°(3,3,3-trifluoro-2- hydroxy-2-methylpropanoyl)amino!benzoique; compositions cosmetiques; utilisations pour le renforcer et/ou preserver la protection anti-oxydante naturelle de la peau
FR2939792B1 (fr) * 2008-12-17 2010-12-17 Oreal Derives de phenyl difluoroacetamide ; compositions les contenants ; utilisations cosmetiques pour renforcer et/ou preserver la protection anti-oxydante naturelle de la peau
FR3015282B1 (fr) 2013-12-20 2016-01-22 Oreal Utilisation cosmetique d'une huile essentielle de laserpitium siler l. pour les matieres keratiniques.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
NZ197008A (en) * 1980-05-22 1984-10-19 Ici Ltd Acylanilide derivatives and pharmaceutical compositions
US4518789A (en) 1982-06-30 1985-05-21 Yu Ruey J Phenyl alpha-acyloxyacetamide derivatives and their therapeutic use
JPS62252711A (ja) * 1986-04-24 1987-11-04 Hideharu Tamaki 養毛剤
GB9214120D0 (en) 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
JP2636118B2 (ja) * 1991-09-10 1997-07-30 三省製薬株式会社 育毛剤
GB2278054A (en) * 1993-05-18 1994-11-23 Zeneca Ltd Compounds for the treatment of urinary incontinence
FR2723311B1 (fr) * 1994-08-02 1996-10-25 Oreal Procede de traitement des fibres keratiniques humaines a l'aide d'amides a chaine grasse et de vapeur d'eau
JP3667153B2 (ja) * 1999-06-17 2005-07-06 キヤノン株式会社 インクジェット記録方法、その記録装置及びコンピュータ可読記憶媒体

Also Published As

Publication number Publication date
EP0886515B1 (de) 2002-01-16
AU2030397A (en) 1997-09-22
US6291532B1 (en) 2001-09-18
ATE211903T1 (de) 2002-02-15
WO1997032562A1 (fr) 1997-09-12
EP0886515A1 (de) 1998-12-30
DE69709628T2 (de) 2002-11-14
ES2171894T3 (es) 2002-09-16
JP2000508296A (ja) 2000-07-04
CA2248198A1 (fr) 1997-09-12
CA2248198C (fr) 2005-09-13

Similar Documents

Publication Publication Date Title
DE69622154D1 (de) Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
DE69719408T2 (de) Verwendung von Strontiumsälze zur Behandlung von Arthrose
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
ATE172634T1 (de) Hemmen von haarwuchs
DE69703649T2 (de) Behandlung von deagglomerierten teilchen mit plasmaaktivierter spezies
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69515070T2 (de) Zusammensetzung auf der Basis von alpha-Pyronen zur Induzierung und Stimulierung des Haarwachstums und/oder zur Verlangsamung des Haarausfalls und ihre Verwendung
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
ATE218355T1 (de) Verwendung von mycobacterium zur tumorbehandlung
DE69709628D1 (de) Verwendung von n-aryl-2-hydroxyalkylamiden zur induzierung und/oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
DE69625877D1 (de) Verwendung von 5-HT1A Rezeptor-Liganden zur Behandlung des Glaukoms
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
BG102015A (en) Azacycloalkane derivatives, their preparation and application in therapy
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
ATE270102T1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE69706195T2 (de) Antikonvulsive derivate zur behandlung von psoriasis
DE69711422T2 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
DE69302250D1 (de) Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia
ATE209910T1 (de) Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen
DE3751059D1 (de) Verwendung von Corticosteroide zur Verringerung von postoperativen Schmerzen.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee